New York A00044 mandates disclosure of information about non-invasive prenatal screening for chromosomal abnormalities.

New York A00044 requires the disclosure of information about non-invasive prenatal screening for chromosomal abnormalities. This includes the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).

New York A00044 mandates disclosure of information about non-invasive prenatal screening for chromosomal abnormalities.

New York A00044 requires the disclosure of information about non-invasive prenatal screening for chromosomal abnormalities. This includes the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).